<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30137688</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>12</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>12</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1349-7006</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>109</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer science</Title>                <ISOAbbreviation>Cancer Sci.</ISOAbbreviation>            </Journal>            <ArticleTitle>OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma.</ArticleTitle>            <Pagination>                <MedlinePgn>3350-3359</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/cas.13770</ELocationID>            <Abstract>                <AbstractText>Metastatic breast cancer is a highly lethal disease, and it is very important to evaluate the biomarkers associated with distant metastasis. However, molecular features of distant metastasis remain largely unknown in breast cancer. Estrogens play an important role in the progression of breast cancer and the majority of stage IV breast carcinomas express estrogen receptor (ER). Therefore, in this study, we examined molecular markers associated with distant metastasis in ER-positive breast carcinoma by microarray and immunohistochemistry. When we examined the gene expression profile of ER-positive stage IV breast carcinoma tissues (n = 7) comparing ER-positive stage I-III cases (n = 11) by microarray analysis, we newly identified OLFM4, LY6D and S100A7, which were closely associated with the distant metastasis. Subsequently, we performed immunohistochemistry for OLFM4, LY6D and S100A7 in 168 ER-positive breast carcinomas. OLFM4, LY6D and S100A7 immunoreactivities were significantly associated with stage, pathological T factor, distant metastasis and Ki67 status in the ER-positive breast carcinomas. Moreover, these immunoreactivities were significantly associated with a worse prognostic factor for distant metastasis-free and breast cancer-specific survival in ER-positive stage I-III breast cancer patients. However, when we performed immunohistochemistry for OLFM4, LY6D and S100A7 in 40 ER-negative breast carcinomas, these immunoreactivities were not generally associated with the clinicopathological factors examined, including distant metastasis and prognosis of patients, in this study. These results suggest that OLFM4, LY6D and S100A7 immunoreactivity are associated with an aggressive phenotype of ER-positive breast carcinoma, and these are potent markers for distant metastasis of ER-positive breast cancer patients.</AbstractText>                <CopyrightInformation>© 2018 The Authors. Cancer Science published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Mayama</LastName>                    <ForeName>Akifumi</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Takagi</LastName>                    <ForeName>Kiyoshi</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Suzuki</LastName>                    <ForeName>Hiroyoshi</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sato</LastName>                    <ForeName>Ai</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Onodera</LastName>                    <ForeName>Yoshiaki</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Miki</LastName>                    <ForeName>Yasuhiro</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sakurai</LastName>                    <ForeName>Minako</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Watanabe</LastName>                    <ForeName>Takanori</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Breast Surgery, National Hospital Organization Sendai Medical Center, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sakamoto</LastName>                    <ForeName>Kazuhiro</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology Medicine, Osaki Citizen Hospital, Osaki, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yoshida</LastName>                    <ForeName>Ryuichi</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Breast Surgery, Osaki Citizen Hospital, Osaki, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ishida</LastName>                    <ForeName>Takanori</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sasano</LastName>                    <ForeName>Hironobu</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology, Tohoku University Hospital, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Suzuki</LastName>                    <ForeName>Takashi</ForeName>                    <Initials>T</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0195-815X</Identifier>                    <AffiliationInfo>                        <Affiliation>Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>25460410</GrantID>                    <Agency>Japanese Ministry of Education, Culture, Sports, Science and Technology.</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>26860229</GrantID>                    <Agency>Japanese Ministry of Education, Culture, Sports, Science and Technology.</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Cancer Sci</MedlineTA>            <NlmUniqueID>101168776</NlmUniqueID>            <ISSNLinking>1347-9032</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D058851">GPI-Linked Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C094237">LY6D protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C454127">OLFM4 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000075023">S100 Calcium Binding Protein A7</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C089242">S100A7 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>143011-72-7</RegistryNumber>                <NameOfSubstance UI="D016179">Granulocyte Colony-Stimulating Factor</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2011 May 10;108(19):7820-5</RefSource>                <PMID Version="1">21518866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2009 Sep;35(3):601-7</RefSource>                <PMID Version="1">19639180</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Med. 2006 Dec;3(12):e467</RefSource>                <PMID Version="1">17194181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2018 Jul 12;:null</RefSource>                <PMID Version="1">29999192</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2007 Jun;12(6):631-5</RefSource>                <PMID Version="1">17602054</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2013 Jul 9;109(1):100-8</RefSource>                <PMID Version="1">23756858</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Metastasis Rev. 2016 Jun;35(2):201-12</RefSource>                <PMID Version="1">27178440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Res Clin Oncol. 2011 Nov;137(11):1713-20</RefSource>                <PMID Version="1">21904905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Histochem Cytochem. 1987 Jun;35(6):683-6</RefSource>                <PMID Version="1">3106467</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Pharmacother. 2017 Feb;86:67-73</RefSource>                <PMID Version="1">27939521</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2009 Mar 10;27(8):1160-7</RefSource>                <PMID Version="1">19204204</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Ther Med. 2010 Jan;1(1):73-78</RefSource>                <PMID Version="1">23136596</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Jan 20;28(3):366-74</RefSource>                <PMID Version="1">20008611</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2002 Jan 31;415(6871):530-6</RefSource>                <PMID Version="1">11823860</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Mar 8;7(10):11165-93</RefSource>                <PMID Version="1">26862846</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2017 Jul;108(7):1510-1519</RefSource>                <PMID Version="1">28394473</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2017 Jun 19;19(1):70</RefSource>                <PMID Version="1">28629450</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CMAJ Open. 2013 Nov 07;1(4):E134-41</RefSource>                <PMID Version="1">25077115</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2007 Mar;98(3):334-40</RefSource>                <PMID Version="1">17270022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2007 Mar;98(3):315-20</RefSource>                <PMID Version="1">17270020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMB Rep. 2012 Nov;45(11):595-603</RefSource>                <PMID Version="1">23186997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Mar 15;132(6):1368-82</RefSource>                <PMID Version="1">22915188</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2018 Oct;109(10):3350-3359</RefSource>                <PMID Version="1">30137688</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 Oct 15;69(20):8035-42</RefSource>                <PMID Version="1">19789344</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Exp Metastasis. 2015 Feb;32(2):125-33</RefSource>                <PMID Version="1">25630269</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Proteomics. 2011 Oct;10(10):M111.011023</RefSource>                <PMID Version="1">21799047</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Cell Dev Biol. 2014 Feb 26;2:6</RefSource>                <PMID Version="1">25364714</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Protein Pept Sci. 2014;15(8):836-42</RefSource>                <PMID Version="1">25466546</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2009 May 20;101(10):736-50</RefSource>                <PMID Version="1">19436038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2004;6(4):153-9</RefSource>                <PMID Version="1">15217486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2010 Jul;134(7):e48-72</RefSource>                <PMID Version="1">20586616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2012 Jan;103(1):136-43</RefSource>                <PMID Version="1">21988594</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Carcinog. 2008 Dec;47(12):956-63</RefSource>                <PMID Version="1">18444244</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2015 Nov;106(11):1642-50</RefSource>                <PMID Version="1">26331797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2004 Apr 1;64(7):2474-81</RefSource>                <PMID Version="1">15059901</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015815" MajorTopicYN="N">Cell Adhesion Molecules</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D058851" MajorTopicYN="N">GPI-Linked Proteins</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016179" MajorTopicYN="N">Granulocyte Colony-Stimulating Factor</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000075023" MajorTopicYN="N">S100 Calcium Binding Protein A7</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">(10-3) Metastasis-associated gene &lt; (10) Invasion and metastasis</Keyword>            <Keyword MajorTopicYN="N">(10-5) Diagnosis of metastasis &lt; (10) Invasion and metastasis</Keyword>            <Keyword MajorTopicYN="N">(13-3) Hormones &lt; (13) Growth factors/cytokines/hormones</Keyword>            <Keyword MajorTopicYN="N">(14-4) Mammary gland &lt; (14) Characteristics and pathology of human cancer</Keyword>            <Keyword MajorTopicYN="N">(15-3) Diagnosis by tumor markers and biomarkers &lt; (15) Diagnosis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>08</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30137688</ArticleId>            <ArticleId IdType="doi">10.1111/cas.13770</ArticleId>            <ArticleId IdType="pmc">PMC6172070</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>